Evaluation of the Long Term Efficacy of Endovascular Treatment of Type 2 Endoleaks

Completed

• Conditions: Abdominal Aortic Aneurysm
• Interventions: Procedure: Type II endoleak treatment

• Registration Number: NCT04409717
• Lead Sponsor: Centre Hospitalier Universitaire Dijon

Brief Summary

Endovascular treatment has become the first choice to repair abdominal aortic aneurym, but exposes patients to a risk of endoleaks. Although treatment of type 1 and 3 endoleaks has proven to prevent aneurysms from rupture, controversies remain about type 2 endoleaks. The investigators described the different techniques of type 2 endovascular repair, and their efficacy at short and long term..

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-01
• Status Verified: 2020-05
• Primary Completion: 2020-05-26
• Study Completion: 2020-05-26
• Study First Submitted: 2020-05-26
• Study First Submitted QC: 2020-05-29
• Last Update Submitted: 2020-05-29
• Study First Posted: 2020-06-01
• Last Update Posted: 2020-06-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 19

Inclusion Criteria

• All patients treated for type II endoleaks by endovascular therapy

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients treated for type II endoleaks	Type II endoleak treatment	Patients treated for type II endoleaks between the 01 January 2008 and the 31 March 2018 in the Cardiovascular and Thoracic Surgery Unit of Dijon Burgundy University Hospital

Primary Outcome Measures

Name	Time	Method
Recurrence rate of type II endoleaks treated with endovascular intervention	12 years

Secondary Outcome Measures

Name	Time	Method
Type of type II endoleaks treatment	12 years

Trial Locations

Locations (1)

Cardiovascular and thoracic surgery unit, CHU Dijon; 🇫🇷 Dijon Cedex, France